Bausch Health Companies (BHC) Enterprise Value (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Enterprise Value came in at $974.3 million in Q2 2026, down 40.24% year-over-year from $1.6 billion in Q2 2025, and down 42.06% quarter-over-quarter from $1.7 billion in Q1 2026.
Analysis
Bausch Health Companies (BHC) Enterprise Value (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Enterprise Value across 18 years of filings, most recently posting $974.3 million for Q2 2026.
- In Q2 2026, Enterprise Value fell 40.24% year-over-year to $974.3 million; the TTM figure through Jun 2026 stood at $974.3 million (down 40.24% YoY), while the FY2025 annual figure was $2.2 billion, down 19.83% from the prior year.
- Enterprise Value came in at $974.3 million for Q2 2026 at Bausch Health Companies, down from $1.7 billion in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of $5.9 billion in Q1 2022 to a low of $974.3 million in Q2 2026.
- Average Enterprise Value over 5 years is $2.8 billion, with a median of $2.8 billion recorded in 2024.
- Year-over-year, Enterprise Value tumbled 76.08% in 2022 and jumped 55.93% in 2023.
- Over 5 years, Enterprise Value stood at $2.6 billion in 2022, then climbed by 10.38% to $2.9 billion in 2023, then dropped by 6.41% to $2.7 billion in 2024, then dropped by 19.83% to $2.2 billion in 2025, then plunged by 55.33% to $974.3 million in 2026.
- Per Business Quant data, the three most recent Enterprise Value figures were $974.3 million in Q2 2026, $1.7 billion in Q1 2026, and $2.2 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 974.33 Mn |
| Mar 31, 2026 | 1.68 Bn |
| Dec 31, 2025 | 2.18 Bn |
| Sep 30, 2025 | 1.97 Bn |
| Jun 30, 2025 | 1.63 Bn |
| Mar 31, 2025 | 2.18 Bn |
| Dec 31, 2024 | 2.72 Bn |
| Sep 30, 2024 | 3.18 Bn |
| Jun 30, 2024 | 2.88 Bn |
| Mar 31, 2024 | 4.08 Bn |
| Dec 31, 2023 | 2.91 Bn |
| Sep 30, 2023 | 3.17 Bn |
| Jun 30, 2023 | 3.26 Bn |
| Mar 31, 2023 | 3.36 Bn |
| Dec 31, 2022 | 2.63 Bn |
| Sep 30, 2022 | 2.95 Bn |
| Jun 30, 2022 | 2.09 Bn |
| Mar 31, 2022 | 5.87 Bn |
| Dec 31, 2021 | 9.41 Bn |
| Sep 30, 2021 | 8.17 Bn |